Closing the Diagnostic Gap: Technology’s Role in Saving Lives

Q: How have your experiences shaped Eden’s mission and strategic vision?

A: Witnessing the consequences of misdiagnoses within my family instilled in me a profound respect for medicine. Observing that healthcare lagged technologically, despite global advances in other sectors, motivated me to transform the field. Eden was born from this mission: to ensure no one suffers or dies due to delayed or incorrect diagnoses. Every decision at Eden, from hiring to product development, centers on this purpose.

Q: How does Eden create measurable value for healthcare institutions while scaling across Latin America?

A: Radiology faces a global shortage of specialists; the average age of radiologists is 55, and populations are aging. This situation leads to overworked physicians, diagnostic errors, and long turnaround times. Eden addresses this through a cloud-based platform that enables tele-diagnosis, while integrating disruptive AI technologies. Our thorax AI model detects up to 10 thoracic pathologies, including early-stage lung cancer, increasing survival from 17% to 76% when identified early. Our language model reduces transcription time, enhancing radiologist productivity by up to 50%. Beyond AI, we optimize operational workflows, serving over 15 million patients across 2,200 imaging departments in 18 countries, including top-tier hospitals like Médica Sur and multinational clients like DASA in Brazil.

Our 100% client retention rate demonstrates the effectiveness of adapting solutions to diverse institutional operations. Health systems are heterogeneous and complex. Transforming workflows and culture requires resilience, field engineering, and close collaboration with medical teams. Scaling to 18 countries and 2,400 departments in four years illustrates both the opportunity and the challenge of transforming healthcare while maintaining high impact.

Q: How does Eden differentiate itself from traditional healthcare companies in pursuing this vision?

A: Eden is designed as the anti-traditional healthcare company. Our name reflects the life-saving impact our platform enables. Over 35,000 individuals receive medical diagnoses daily through Eden, with more than 80,000 portal accesses per day by physicians and patients making treatment decisions. From routine care to critical interventions — such as chemotherapy protocols for children at the Teletón oncology center or life-saving heart transplants — our platform supports decisions that directly affect patient survival. We embrace this responsibility fully, combining advanced technology with a mission-driven approach that places purpose and impact at the core of our operations.

Q: How does Eden leverage data and AI to drive clinical impact while ensuring solutions are tailored to local patient populations?

A: Data has always been central to preventing deaths from delayed or incorrect diagnoses. We access anonymized client data for R&D, enabling the development of innovations relevant to Latin America. For example, our thorax AI model is trained on millions of Latin American radiology studies, reflecting anatomical and physiological differences that models trained in the United States or South Korea are less likely to perceive. Unlike companies that only supply algorithms, we control workflows, allowing us to measure whether AI improves diagnostic accuracy or efficiency. We spend roughly 60% of our time in the field with clients and radiologists, co-innovating and addressing real-world challenges to ensure solutions are practical, focused, and impactful for local healthcare systems.

Q: How does Eden navigate regulatory frameworks and ensure interoperability while maintaining data security and operational effectiveness?

A: Compliance and interoperability are critical. Regulatory frameworks in Latin America vary, and the region often lacks clear guidelines. We collaborate with authorities, such as COFEPRIS in Mexico, and adhere to regulations in Colombia and Brazil, as well as international standards like HIPAA, FDA, ISO 27001, and ISO 13485. 

Interoperability addresses a major cause of misdiagnoses: fragmented data. Clinicians often lack access to comprehensive patient histories. Eden integrates with over 200 systems via API, consolidating diagnostic data. Our language models also help connect, analyze, and make this data actionable across radiology, pathology, genomics, and laboratory studies, processing over 1 million non-radiology studies to date.

Q: What are Eden’s expansion priorities for the next three to five years?

A: Our vision is to build a universal diagnostic engine capable of analyzing all patient diagnostic data and delivering actionable insights to physicians. The first step was accessing imaging data, the foundation of diagnosis. Over the next three to five years, we aim to consolidate leadership in Latin America, particularly in Mexico and Brazil, while establishing a presence in the United States. While many believe that the United States is more technologically advanced, many of its institutions operate on outdated infrastructure, presenting significant opportunities. Our goal is to provide accessible, high-quality diagnostic intelligence to billions of potential patients across the world.

Eden develops cutting-edge software aiming to make diseases like cancer non-lethal within our lifetime. Serving over 2,000 clients across 17 countries, it is Latin America’s leading medical imaging solution.